Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

No quotes available
-- USD   --.--%
06/25 CANADA'S VALEAN : Wsj
06/25DJELI LILLY : Wins Alimta Patent Case in U.K.
06/25DJELI LILLY : Wins Alimta Patent Case in U.K.
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ACTAVIS INC
2012 WATSON PHARMACEUTICALS, INC. : Watson Applauds GPhA Study Demonstrating $1 Trill..
2012 WATSON PHARMACEUTICALS, INC. : Watson's Generic Version of Pulmicort RESPULES® R..
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms Xopenox HFA® Patent Challenge
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms Epiduo® Gel Patent Challenge
2012 WATSON PHARMACEUTICALS, INC. : Watson Second Quarter 2012 Non-GAAP Diluted EPS I..
2012DJWATSON PHARMACEUTICALS : FDA Approves Generic of Teva's Plan B Emergency Contrac..
2012 WATSON PHARMACEUTICALS, INC. : Watson's Generic Version of Plan B One-Step® Rece..
2012 WATSON PHARMACEUTICALS, INC. : Watson and Actavis Receive FTC Second Request
2012 WATSON PHARMACEUTICALS, INC. : Watson's Generic ARTHROTEC(R) Receives FDA Approv..
2012DJCorrection to Shire's Generic Adderall XR Approval Story On June 25
2012 WATSON PHARMACEUTICALS, INC. : Watson to Host Second Quarter 2012 Earnings Confe..
2012DJWest Virginia Attorney General Sues Drug Distributors in Pill Abuse Fight
2012DJU.S. HOT STOCK FUTURES : Hot stocks to watch
2012DJU.S. HOT STOCK FUTURES : Hot stocks to watch
2012DJWatson Seeks FDA Approval Of Generic Pristiq
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms Pristiq® Patent Challenge
2012DJShire Sinks On Generic Adderall XR Approval But Rebound Seen
2012 WATSON PHARMACEUTICALS, INC. : /C O R R E C T I O N -- Watson Pharmaceuticals, I..
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms Favorable Appeals Court Decision ..
2012 WATSON PHARMACEUTICALS, INC. : Watson to Present at Goldman Sachs Global Healthc..
2012DJMylan Launches Generic Version of Blockbuster Lipitor
2012DJUS HOT STOCK FUTURES : Hot stocks to watch
2012 WATSON PHARMACEUTICALS, INC. : Watson Announces Lidoderm® Patent Challenge Settl..
2012 WATSON PHARMACEUTICALS, INC. : Watson to Present at the Jefferies 2012 Global He..
2012DJUS HOT STOCK FUTURES : Hot stocks to watch
2012DJUS HOT STOCK FUTURES : Hot stocks to watch
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms Testim® Patent Challenge
2012 WATSON PHARMACEUTICALS, INC. : Watson to Present at the Sanford C. Bernstein 28t..
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms Lo Loestrin® Fe Patent Challenge
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms Lialda® Patent Challenge
2012 WATSON PHARMACEUTICALS, INC. : Watson Announces Formation of Global Integration ..
2012 WATSON PHARMACEUTICALS, INC. : Watson to Present at the Bank of America Merrill ..
2012 WATSON PHARMACEUTICALS, INC. : Watson Names Lisa DeFrancesco Vice President, Glo..
2012DJPfizer Profit Falls 19% As Generics Hurt Lipitor Sales
2012DJUPDATE : Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales
2012 WATSON PHARMACEUTICALS, INC. : Watson Pharmaceuticals To Webcast Annual Meeting ..
2012DJPfizer Profit Falls 19% As Generics Hurt Lipitor Sales
2012 Warner Chilcott to explore sale of company
2012DJUS STOCK FUTURES : Hot stocks to watch
2012 WATSON PHARMACEUTICALS, INC. : Watson First Quarter 2012 Non-GAAP EPS Increases ..
2012DJPharma M&A Surge Spurred By Necessity And Opportunity
2012 WATSON PHARMACEUTICALS, INC. : Watson Announces Restructuring of Senior Leadersh..
2012DJUS Stocks Climb As Housing Data Outweighs Weak Labor, Europe Readings
2012DJINTERVIEW : Actavis CEO To Leave Company After Watson Integration
2012 WATSON PHARMACEUTICALS, INC. : Watson and Antares Announce the Introduction of G..
2012 WATSON PHARMACEUTICALS, INC. : QRxPharma's US Commercialisation Partner, Actavis..
2012 WATSON PHARMACEUTICALS, INC. : Watson to Acquire Actavis Group for EUR 4.25 Bill..
2012 Watson to buy Actavis for at least $5.6 billion
2012DJDeutsche Bank Takes EUR257 Million Hit On Actavis-Watson Deal
2012 Deutsche Bank says Actavis deal shores up capital
2012 WATSON PHARMACEUTICALS, INC. : Video: Watson to Acquire Actavis Group for EUR4.2..
2012 WATSON PHARMACEUTICALS, INC. : Watson to Acquire Actavis Group for EUR4.25 Billi..
2012DJWatson, Actavis To Unveil EUR4.5 Billion Merger Deal Wednesday
2012DJWATSON, ACTAVIS TO UNVEIL DEAL ON WE : Sources - Reuters
2012 WATSON PHARMACEUTICALS, INC. : Watson to Host Conference Call and Webcast to Dis..
2012 WATSON PHARMACEUTICALS, INC. : Watson Launches Generic FORTAMET(R)
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms Glumetza® Patent Challenge
2012 WATSON PHARMACEUTICALS, INC. : Watson's Generic VANCOCIN® HCl Capsules Receive F..
2012DJWatson Says Received Favorable Ruling Over Generic Sanctura XR
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms Favorable District Court Ruling i..
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms LUMIGAN(R) and LATISSE(R) Patent ..
2012 Ranbaxy starts generic Lipitor shipments from India
2012 EXCLUSIVE : Watson close to $7 billion Actavis drug deal: sources
2012DJDrug Maker Watson To Buy Actavis For About EUR4.5 Billion - Source
2012DJWatson Pharmaceuticals Said Close To Buy Of Actavis For $7 Billion -Reuters
2012 WATSON PHARMACEUTICALS, INC. : Watson's Generic BONIVA® 150mg Receives FDA Appro..
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms NIASPAN(R) Patent Challenge
2012DJWatson Pharma Seeks FDA Approval of Generic Version Of Bystolic
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms BYSTOLIC(R) Patent Challenge
2012DJForest Labs, Janssen Sue Several Drug Makers Over Bystolic
2012 WATSON PHARMACEUTICALS, INC. : Watson Announces Initiation of Esmya(R) U.S. Phas..
2012 WATSON PHARMACEUTICALS, INC. : Watson Launches Generic PROMETRIUM(R)
2012 WATSON PHARMACEUTICALS, INC. : Watson to Present at the Barclays Capital 2012 Gl..
2012 WATSON PHARMACEUTICALS, INC. : Watson Receives Complete Response Letter from FDA..
2012 WATSON PHARMACEUTICALS, INC. : Watson to Present at the 2012 RBC Capital Markets..
Prev.1   2  3  4  5  6Next
Advertisement
Income Statement Evolution
More Financials